Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Textual)

v3.19.3
Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Sep. 26, 2019
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2019
Summary of Significant Accounting Policies (Textual)        
Negative operating cash flows   $ (2,534,151) $ (1,670,983)
Accumulated deficit   (115,331,861)   (111,662,367)
Promissory notes converted       8,030,365
Proceeds from sale of common stock and warrants   $ 825,749   17,760,635
Additional amount from sale of common stock and warrant       $ 1,275,749
Private placements transaction related, description       The Company has received approximately $2,017,000 in cash from exercises of outstanding warrants, which resulted in the Company having approximately $8,010,000 in cash and cash equivalents at November 8, 2019. Based on its budgeted cash flow requirements, the Company believes these funds are sufficient to fund its ongoing operations for at least one year after the issuance of these consolidated quarterly financial statements. The Company expects that the cash burn rate for the 12 months ended December 31, 2020, will be between $5-6 million, which includes approximately $2 million of discretionary research and development (R&D) spending, as the data analysis on the Phase 2a clinical trial is completed and the planning and preparation for the next clinical trial is conducted.
Common stock, shares authorized   50,000,000   50,000,000
Number of authorized common shares 200,000,000      
Reverse stock split, description The Company's Board of Directors approved a 1-to-4 reverse split of the Common Stock, which was effective on the NASDAQ Capital Market on September 30, 2019. As a result of the reverse stock split, every 4 shares of issued and outstanding common stock were converted into 1 share of issued and outstanding common stock, with all fractional shares rounded up to the nearest whole share, and the Company's authorized share of common stock were reduced from 200,000,000 to 50,000,000 shares. All share and per share amounts have been retroactively restated to reflect this reverse stock split.      
Computers and software [Member]        
Summary of Significant Accounting Policies (Textual)        
Estimated useful life   3 years   3 years
Furniture and fixtures [Member]        
Summary of Significant Accounting Policies (Textual)        
Estimated useful life       7 years